JAMA Author Interviews

Scopolamine Butylbromide for Preventing End-of-Life Death Rattle

10.05.2021 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Death rattle, defined as noisy breathing caused by the presence of mucus in the respiratory tract, is common among dying patients. Harriette van Esch, MD, from the Erasmus Medical Center, the Netherlands, and Jared R. Lowe, MD, from the University of North Carolina, join JAMA Associate Editor Ethan Basch, MD, to discuss evidence about use of prophylactic scopolamine butylbromide to reduce the death rattle. Related Content: Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide

More episodes from JAMA Author Interviews